• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌小鼠模型中内皮细胞的分子指纹识别与自分泌生长调节

Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.

作者信息

Ryschich Eduard, Lizdenis Paulius, Ittrich Carina, Benner Axel, Stahl Simone, Hamann Alf, Schmidt Jan, Knolle Percy, Arnold Bernd, Hämmerling Günter J, Ganss Ruth

机构信息

Department of Surgery, University of Heidelberg, Germany.

出版信息

Cancer Res. 2006 Jan 1;66(1):198-211. doi: 10.1158/0008-5472.CAN-05-1636.

DOI:10.1158/0008-5472.CAN-05-1636
PMID:16397233
Abstract

In a mouse model of hepatocellular carcinogenesis, highly vascularized tumors develop through two distinct morphologic phases of neovascularization. We show that increased vascular caliber occurs first, followed by extensive vessel sprouting in late-stage carcinomas. To define molecular pathways in tumor neovascularization, endothelial cells were directly purified from normal liver and advanced tumors. Gene expression profiling experiments were then designed to identify genes enriched in the vascular compartment. We report that Cathepsin S is the major protease specifically overexpressed during vessel sprouting. We also show that the CC chemokines CCL2 and CCL3 are secreted by neovessels and stimulate proliferation through their cognate receptors in an autocrine fashion. This suggests that chemokine signaling represents the most prominent signaling pathway in tumor-associated endothelial cells and directly regulates vessel remodeling. Furthermore, high angiogenic activity is associated with attenuated lymphocyte extravasation and correlates with expression of the immunomodulatory cytokine interleukin 10. This is the first comprehensive study addressing liver-specific vascular changes in a murine autochthonous tumor model. These novel insights into liver angiogenesis infer an environmental control of neovascularization and have important implications for the design of antiangiogenic therapies.

摘要

在肝细胞癌发生的小鼠模型中,高度血管化的肿瘤通过两个不同的新生血管形成形态学阶段发展。我们发现血管口径首先增大,随后在晚期癌中出现广泛的血管芽生。为了确定肿瘤新生血管形成中的分子途径,从正常肝脏和晚期肿瘤中直接纯化内皮细胞。然后设计基因表达谱实验以鉴定在血管区室中富集的基因。我们报告组织蛋白酶S是在血管芽生期间特异性过度表达的主要蛋白酶。我们还表明,CC趋化因子CCL2和CCL3由新生血管分泌,并通过其同源受体以自分泌方式刺激增殖。这表明趋化因子信号传导是肿瘤相关内皮细胞中最突出的信号传导途径,并直接调节血管重塑。此外,高血管生成活性与淋巴细胞渗出减弱相关,并与免疫调节细胞因子白细胞介素10的表达相关。这是第一项针对小鼠原位肿瘤模型中肝脏特异性血管变化的综合研究。这些关于肝脏血管生成的新见解推断了对新生血管形成的环境控制,并对抗血管生成疗法的设计具有重要意义。

相似文献

1
Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.肝细胞癌小鼠模型中内皮细胞的分子指纹识别与自分泌生长调节
Cancer Res. 2006 Jan 1;66(1):198-211. doi: 10.1158/0008-5472.CAN-05-1636.
2
HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.HSulf-1在体内抑制血管生成和肿瘤发生。
Cancer Res. 2006 Jun 15;66(12):6025-32. doi: 10.1158/0008-5472.CAN-05-3582.
3
Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.成纤维细胞生长因子受体1在肝细胞中的异位活性通过驱动增殖和血管内皮生长因子诱导的血管生成来加速肝癌发生。
Cancer Res. 2006 Feb 1;66(3):1481-90. doi: 10.1158/0008-5472.CAN-05-2412.
4
Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.Wnt信号通路的阻断抑制肝细胞癌中的血管生成和肿瘤生长。
Cancer Res. 2009 Sep 1;69(17):6951-9. doi: 10.1158/0008-5472.CAN-09-0541. Epub 2009 Aug 18.
5
Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.血管内皮生长因子受体-1在小鼠肝细胞癌发生中的作用。
J Hepatol. 2004 Jul;41(1):97-103. doi: 10.1016/j.jhep.2004.03.001.
6
Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.肝细胞生长因子和诱导型一氧化氮合酶参与肝癌细胞系中多药耐药诱导的血管生成。
Cancer Res. 2006 Mar 1;66(5):2673-82. doi: 10.1158/0008-5472.CAN-05-2290.
7
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.生长激素在血管病理学中的作用:新生血管形成及受体表达与细胞增殖相关。
Anticancer Res. 2007 Nov-Dec;27(6B):4201-18.
8
Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.在小鼠中,Ephrin-A1通过由EphA受体和血管内皮生长因子介导的血管生成依赖性机制促进乳腺肿瘤转移。
Cancer Res. 2006 Nov 1;66(21):10315-24. doi: 10.1158/0008-5472.CAN-06-1560.
9
Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.莫氏肝癌中血管生成素-2的过表达导致肿瘤灌注增加并诱导关键的血管生成促进基因。
J Nucl Med. 2006 Sep;47(9):1515-24.
10
Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.血管紧张素原可延缓转基因小鼠肝癌的血管生成和肿瘤生长。
Cancer Res. 2009 Apr 1;69(7):2853-60. doi: 10.1158/0008-5472.CAN-08-2484. Epub 2009 Mar 24.

引用本文的文献

1
DNASE1L3 enhances antitumor immunity and suppresses tumor progression in colon cancer.DNASE1L3 增强结肠癌的抗肿瘤免疫并抑制肿瘤进展。
JCI Insight. 2023 Sep 8;8(17):e168161. doi: 10.1172/jci.insight.168161.
2
ECM Depletion Is Required to Improve the Intratumoral Uptake of Iron Oxide Nanoparticles in Poorly Perfused Hepatocellular Carcinoma.在灌注不良的肝细胞癌中,需要消耗细胞外基质以改善氧化铁纳米颗粒的瘤内摄取。
Front Oncol. 2022 Feb 22;12:837234. doi: 10.3389/fonc.2022.837234. eCollection 2022.
3
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery.
新型载药纳米载体在癌症免疫治疗中对组织蛋白酶 S 抑制剂的应用
Cells. 2020 Sep 2;9(9):2021. doi: 10.3390/cells9092021.
4
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.趋化因子及其受体:在癌症进展中的多方面作用及作为癌症预后标志物的潜在价值
Cancers (Basel). 2020 Jan 24;12(2):287. doi: 10.3390/cancers12020287.
5
Immune-mediated ECM depletion improves tumour perfusion and payload delivery.免疫介导的细胞外基质耗竭可改善肿瘤灌注和有效载荷传递。
EMBO Mol Med. 2019 Dec;11(12):e10923. doi: 10.15252/emmm.201910923. Epub 2019 Nov 11.
6
Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.G 蛋白偶联受体在肝细胞癌中的新兴作用。
Int J Mol Sci. 2018 May 4;19(5):1366. doi: 10.3390/ijms19051366.
7
Analysis of expression profile data identifies key genes and pathways in hepatocellular carcinoma.对表达谱数据的分析确定了肝细胞癌中的关键基因和通路。
Oncol Lett. 2018 Feb;15(2):2625-2630. doi: 10.3892/ol.2017.7534. Epub 2017 Dec 6.
8
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.一种具有生物活性的组织蛋白酶S腈类抑制剂可消除肿瘤发展。
Mol Cancer. 2016 Apr 21;15:29. doi: 10.1186/s12943-016-0513-7.
9
Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow.血流状态下壁面剪应力和配体亲和力对抗CD146包被纳米颗粒与小鼠肿瘤内皮细胞结合的影响。
Oncotarget. 2015 Nov 24;6(37):39960-8. doi: 10.18632/oncotarget.5662.
10
Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.趋化因子及其受体在肝细胞癌的发展过程中发挥着重要作用。
World J Hepatol. 2015 Jun 8;7(10):1390-402. doi: 10.4254/wjh.v7.i10.1390.